PAX Health Acquires MAKRAF IME, Expanding Independent Medical Examination Services Across New Jersey

IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs

Kashi Introduces New Kashi Gut Health Granola

Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time

Batlin Recovery Center Launches Medically Monitored Detox Services

BRIJ Medical Launches BRIJ-SEAL™, Expanding Its Incision Management Portfolio with an Advanced Wound Sealant

SystImmune Announces Second Approval of Iza-bren in China for the Treatment of Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY

Luvme Hair Shares Expert Guide to Scalp Comfort With Crochet Hair

Medical Plastics Tubing Market worth $6.81 billion by 2031 - Exclusive Report by MarketsandMarkets™

First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Moët Hennessy and Formula 1® unveil The Out Lap: the world's first moving fine dining experience on a Formula 1 circuit

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

Tampa General Hospital First in the Nation to Sign Nutrition Pledge

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

ESCMID Global : la vaccination maternelle contre le VRS réduit de plus de 80% le risque d'hospitalisation des nourrissons, selon une importante étude de l'UKHSA

ESCMID Global: RSV-Impfung während der Schwangerschaft senkt das Hospitalisierungsrisiko bei Säuglingen um mehr als 80 Prozent, wie eine große UKHSA-Studie zeigt

ASC Ortho Management Company, LLC d/b/a Aligned Orthopedic Partners Provides Notice Following Data Security Incident

SK Life Science Labs to Present New Preclinical Data on Targeted Protein Degradation at AACR Annual Meeting 2026

In HelloNation, Wealth Advisor Ted Thatcher Explains Managing Healthcare Costs in Retirement

New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026

Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Simpli5 Team Intelligence Platform Linked to Measurable Gains in Clinical Quality Across Healthcare Organizations

Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting

Nested Therapeutics Reports Initial Encouraging Clinical Activity and Favorable Tolerability of NST-628, a Brain-Penetrant Pan-RAF/MEK Molecular Glue, at AACR 2026

Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer

Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting

UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

Tampa General Hospital Cancer Institute Earns Reaccreditation from the American College of Surgeons Commission on Cancer